Browsing by Author Shannon, Jenny

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)Citation
2010Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasBrown, Christopher; Gainford, Mary; Gebski, Val; Miller, Danielle; Abdi, Ehtesham A; Ackland, Stephen P.; Goldstein, D; Jefford, Michael; Selva-Nayagam, Sid; Shannon, Jenny; Tebbutt, Niall C; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreFixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas, Cancer Chemotherapy and Pharmacology, vol.0, 0,pp 1-7
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2018Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinomaGibbs, Emma; Martin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Gill, Sanjeev; Goldstein, David; Jain, Vikram; Kannourakis, G; Kim, Jin Won; Kim, Yeul Hong; Liu, Geoffrey; Price, Timothy; Shannon, Jenny; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHealth-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma, Gastric Cancer, vol.21, 3, 2018,pp 473-480
2009Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survivalGebski, Val; Morgan, Gary; Oddone, Nicolas; Palme, Carsten; Perera, Lakmalie; Shannon, Jenny; Veness, Michael; Wong, Eva; School of Public Health: NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Surgery; Western Clinical School: Surgery; Western Clinical School: Medicine (Westmead); Nepean Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival, Cancer, vol.115, 9,pp 1883-1891
2014Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 TrialShannon, Jenny; Campbell, Fiona; Costello, Eithne; Cox, Trevor; et al, Various; Garner, Elizabeth; Ghaneh, Paula; Greenhalf, William; Lamb, Richard; Mackey, John; Moore, Malcolm; Neoptolemos, John P.; Palmer, Daniel; Nepean Clinical School: MedicinePancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial, National Cancer Institute. Journal, vol.106, 1, 2014,pp 1-10
2016Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trialFerraro, Danielle Angela; Gebski, Val; Hall, Merryn; Pavlakis, Nick; Sjoquist, Katrin; Veillard, Anne-Sophie; Wong, Nicole; Cooray, Prasad; Ganju, V.; Price, Timothy; Shannon, Jenny; Strickland, A. H.; Tebbutt, Niall; Underhill, Craig; Varma, S; Young, Rosemary; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePanitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial, British Journal of Cancer, vol.114, 5, 2016,pp 505-509
2014Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialEl-Tahche, Fabyolla; Shannon, Jenny; Alcindor, Thierry; Au, Heather-Jane; Easaw, Jay C; et al, Various; Jeffery, Mark; Jonker, Derek J.; Kotb, Rami; Moore, Malcolm; Ng, Siobhan; Ringash, Jolie; Sabesan, Sabe; Salim, Muhammad; Shapiro, Jeremy; Siu, Lillian L; Strickland, A. H.; Zalcberg, John; Central Clinical School: Medicine; Nepean Clinical School: MedicineQuality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial, Cancer, vol.120, 2, 2014,pp 181-189
2011Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumabCummins, Michelle; Marx, Gavin; Shannon, Jenny; Simes, Robert John; Wilson, Kate; Zannino, Diana; Abdi, Ehtesham A; Blum, R; Chantrill, L; Goldstein, D; Karapetis, Christos; Lowenthal, Raymond M.; Murphy, F; Nayagam, S; Price, Timothy; Strickland, A. H.; Tebbutt, Niall C; School of Public Health: NH&MRC Clinical Trials Centre; Medicine; Nepean Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreRisk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab, Annals of Oncology, vol.22, 8, 2011,pp 1834-1838
2016Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysisEslick, Guy; Sabanathan, Dhanusha; Shannon, Jenny; Nepean Clinical School: SurgeryUse of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis, Clinical Colorectal Cancer, vol.15, 4, 2016,pp e141-e147
2016Use of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysisEslick, Guy; Sabanathan, Dhanusha; Shannon, Jenny; Nepean Clinical School: SurgeryUse of Neoadjuvant Chemotherapy Plus Molecular Targeted Therapy in Colorectal Liver Metastases: A Systematic Review and Meta-analysis, Clinical Colorectal Cancer, vol.15, 4, 2016,pp e141-e147